Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages

No definition available.

Name:	mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages
Namespace Prefix:	mck_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	instant

- Definition

Litigation Settlement, Award Amount To Be Used by State and Local Government

+ References

No definition available.

+ Details

Name:	mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
Namespace Prefix:	mck_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Claims Settled, Number Of Jurisdictions Not Participating In Settlement

+ References

No definition available.

+ Details

Name:	mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number Of Cases Dismissed

+ References

No definition available.

+ Details

Name:	mck_LossContingencyNumberOfCasesDismissed
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of Other Defendants

+ References

No definition available.

+ Details

Name:	mck_LossContingencyNumberOfOtherDefendants
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of States

+ References

No definition available.

+ Details

Name:	mck_LossContingencyNumberofStates
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Party Substitution Period to Prevent Case Dismissal

+ References

No definition available.

+ Details

Name:	mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal
Namespace Prefix:	mck_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.

+ References

+ Details

Name:	us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of damages awarded to the plaintiff in the legal matter.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingencyDamagesAwardedValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of pending claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of cash paid for the settlement of litigation or for other legal issues during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-8

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(1)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

+ Details

Name:	us-gaap_RestrictedCash
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=mck_CorporateSegmentAndU.S.PharmaceuticalSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=country_CA
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_IndividualClaimantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndCherokeeNationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=mck_ThreeLargestUSPharmaceuticalDistributorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_CherokeeNationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingent Liabilities - Litigation and Claims Involving Distribution of Controlled Substances (Narrative) (Details) $ in Millions			12 Months Ended
	Nov. 12, 2024 USD ($)	Feb. 25, 2019	Mar. 31, 2025 USD ($) case jurisdiction state distributor	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Feb. 12, 2025 USD ($)	Nov. 27, 2024 USD ($)
Loss Contingencies [Line Items]
Litigation settlement charges			$ 108	$ 147	$ (8)
National Prescription Opiate Litigation
Loss Contingencies [Line Items]
Number of jurisdictions that did not participate in settlement \| jurisdiction			1
Litigation settlement charges			$ 114	149
National Prescription Opiate Litigation \| Corporate Segment And U.S. Pharmaceutical Segment
Loss Contingencies [Line Items]
Litigation settlement charges			$ 57
National Prescription Opiate Litigation \| Corporate
Loss Contingencies [Line Items]
Litigation settlement charges				75
National Prescription Opiate Litigation \| U.S. Pharmaceutical
Loss Contingencies [Line Items]
Litigation settlement charges				74
Canada \| National Prescription Opiate Litigation
Loss Contingencies [Line Items]
Number of complaints served \| case			4
Individual Claimant \| Canada \| National Prescription Opiate Litigation
Loss Contingencies [Line Items]
Number of complaints served \| case			1
National Prescription Opiate Litigation
Loss Contingencies [Line Items]
Number of other defendants \| distributor			2
Number of states \| state			48
Loss contingency, number of cases dismissed \| case			2,300
Litigation settlement, award amount to be used by state and local government			85.00%
Amounts awarded to plaintiff	$ 192
Restricted cash						$ 114	$ 149
National Prescription Opiate Litigation \| State of Alabama and Subdivisions
Loss Contingencies [Line Items]
Payments for legal settlements			$ 75
Aggregate amount expected to be paid			99
National Prescription Opiate Litigation \| Settling Governmental Entities and Cherokee Nation \| Settled Litigation
Loss Contingencies [Line Items]
Payments for legal settlements			$ 515	$ 544	$ 1,100
National Prescription Opiate Litigation \| Native American Tribes Other Than Cherokee Nation
Loss Contingencies [Line Items]
Percentage of total settlement to be used to remediate damages (in percent)			0.85
National Prescription Opiate Litigation \| Three Largest U.S. Pharmaceutical Distributors
Loss Contingencies [Line Items]
Payments for legal settlements			$ 2,000
Aggregate amount expected to be paid			5,900
National Prescription Opiate Litigation \| Three National Pharmaceutical Distributors \| State of West Virginia and Subdivisions
Loss Contingencies [Line Items]
Payments for legal settlements			68
National Prescription Opiate Litigation \| Three National Pharmaceutical Distributors \| State of West Virginia and Subdivisions \| Settled Litigation
Loss Contingencies [Line Items]
Aggregate amount expected to be paid			84
National Prescription Opiate Litigation \| Three National Pharmaceutical Distributors \| Cherokee Nation
Loss Contingencies [Line Items]
Payments for legal settlements			112
Aggregate amount expected to be paid			$ 84
United States ex rel. Manchester v. Purdue Pharma, L.P., et al
Loss Contingencies [Line Items]
Period within which party can be substituted		90 days